, Volume 37, Issue 4, pp 842-848,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 03 Mar 2010

Guidelines for the labelling of leucocytes with 99mTc-HMPAO


We describe here a protocol for labelling autologous white blood cells with 99mTc-HMPAO based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.

Erik F. J. de Vries and Manel Roca contributed equally to this work.
These guidelines summarize the views of the Inflammation/Infection Taskgroup of the EANM and reflects recommendations for which the EANM cannot be held responsible. The recommendations should be taken in the context of good practice of nuclear medicine and do not substitute for national and international legal or regulatory provisions.
The guidelines have been reviewed by the EANM Dosimetry Committee and the Radiopharmacy Committee.
The guidelines have been brought to the attention of the National Societies of Nuclear Medicine.
An erratum to this article can be found at http://dx.doi.org/10.1007/s00259-010-1461-x